Join
Live feed
·
INSIDERFilingvia Quantisnow
Cullinan Therapeutics Inc. logo

Chief Financial Officer Fenton Mary Kay was granted 68,750 shares, increasing direct ownership by 111% to 130,778 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CGEM· Cullinan Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CGEM (Cullinan Therapeutics Inc.) and more on Quantisnow.